While those taking semaglutide (Wegovy) and tirzepatide (Mounjaro) lost double the amount of weight compared with people using older jabs 16kg on average patients put on 9.6kg within a year, meaning they could expect to regain all 16kg again in just over 20 months
The 2-year STEP 5 study discussed here aimed to assess the sustained impact of weekly subcutaneous semaglutide 2.4 mg, in conjunction with behavioral interventions, on body weight and cardiometabolic risks among non-diabetic adults grappling with obesity (BMI 30 kg m2) or overweight (BMI 27 kg m2 with at least one related comorbidity)
These check-ins include reviewing weight loss progress, tracking any side effects, and addressing any concerns that may arise
Keep the button pressed and count to 6 seconds after the dose counter reaches 0, ensuring complete medication delivery as instructed in the Ozempic Patient Information Leaflet Needle withdrawal : Release the skin pinch before withdrawing the needle to prevent medication leakage Post-injection care : Do not rub the injection site vigorously, as this may increase irritation and bruising risk
Any previous injuries or conditions that may be contributing to your pain (e.g., arthritis, herniated discs, or muscle strain)
